Press release
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
U.S. Centers for Medicare & Medicaid Services has approved coverage for Dexcom G7, the most accurate,1 easy-to-use CGM system that helps people with diabetes
About this update from Dexcom, Inc.
[{"type":"text","content":"\n\nU.S. Centers for Medicare & Medicaid Services has approved coverage for Dexcom G7, the most accurate,1 easy-to-use CGM system that helps people with diabetes gain greater control of their health.\n\n\nIntroduced to the world yesterday in a Super Bowl ad, Dexcom G7 eliminates routine fingersticks* and builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C and increase time in range.2-6\n\n\nThe approval of Medicare coverage for Dexcom G7 further solidifies Dexcom as the most covered and reimbursed CGM brand on the market.7\n\n\nPeople with diabetes in the US, including Medicare patients, can visit Dexcom.com/G7 today to get started with Dexcom G7.\n\n\n SAN DIEGO--(BUSINESS WIRE)--\nDexcom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today its next-generation Dexcom G7 CGM System will be covered for Medicare beneficiaries.† Having met the category requirements for therapeutic CGM systems set forth by the U.S. Centers for Medicare & Medicaid Services, Dexcom G7 will be accessible to all Medicare patients with diabetes who meet the eligibility criteria when the system launches this Friday, Feb. 17.\n\n“When we set out to design G7, our goal was simple: to make the most accurate, easy-to-use CGM available for as many people with diabetes as possible,” said Kevin Sayer, chairman, president and CEO of Dexcom. “The approval of Medicare coverage for G7 helps us deliver on that promise. Now Medicare patients with Type 1 and Type 2 diabetes will have access to the newest CGM technology that offers the most reliable, simple way to help people manage their diabetes more confidently.”\n\nThe most accurate,1 easy to use CGM available will be covered by Medicare at launch.\n\nWith Dexcom G7, the #1 recommended CGM brand8,9 now offers the most accurate1 and simple way to help people gain greater control of their diabetes. Its low-profile, all-in-one wearable warms up faster than any other CGM on the market,‡ sending real-time glucose readings automatically to a compatible smart device§ or receiver, no painful fingersticks* or burdensome scanning required. With an overall MARD of 8.2%, Dexcom G7 is the most accurate CGM on the market,1 building on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyp...